ID

24291

Descrição

Study ID: 100468 Clinical Study ID: AVA100468 Study Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Avandia XR,Rosiglitazone XR,Avandia Study Indication: Alzheimer's Disease Study Conclusion

Palavras-chave

  1. 28/07/2017 28/07/2017 -
Titular dos direitos

GlaxoSmithKline

Transferido a

28 de julho de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC-ND 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

Patient Information
Descrição

Patient Information

Alias
UMLS CUI-1
C1955348
Subject Identifier
Descrição

Subject Identifier

Tipo de dados

text

Alias
UMLS CUI [1]
C2348585
Pregnancy Information
Descrição

Pregnancy Information

Alias
UMLS CUI-1
C0032961
Did the subject become pregnant during the study?
Descrição

If Yes, complete Pregnancy Notification form.

Tipo de dados

text

Alias
UMLS CUI [1]
C0032961
Study Conclusion
Descrição

Study Conclusion

Alias
UMLS CUI-1
C1707478
Date of subject completion or withdrawal
Descrição

Completion, Withdrawal

Tipo de dados

date

Unidades de medida
  • dd-mmm-yy
Alias
UMLS CUI [1]
C0805732
UMLS CUI [2]
C2349954
dd-mmm-yy
Was the subject withdrawn from the study?
Descrição

* If YES, specify the primary reason.

Tipo de dados

text

Alias
UMLS CUI [1]
C2349954
If Yes, tick the primary reason for withdrawal:
Descrição

Primary Reason of Withdrawal

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
If Yes, tick the primary reason for withdrawal: If Other, specify:
Descrição

Primary Reason of Withdrawal Specification

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
UMLS CUI [1,3]
C2348235
Investigator's Signature
Descrição

Investigator's Signature

Alias
UMLS CUI-1
C2346576
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below. Investigator's name (print)
Descrição

Investigature's name

Tipo de dados

text

Alias
UMLS CUI [1]
C2346576
Date of Report
Descrição

Date of Report

Tipo de dados

date

Unidades de medida
  • dd-mmm-yy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yy

Similar models

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1])
Code List
Did the subject become pregnant during the study?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not Applicable (not of childbearing potential or male) (X)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
Completion, Withdrawal
Item
Date of subject completion or withdrawal
date
C0805732 (UMLS CUI [1])
C2349954 (UMLS CUI [2])
Item
Was the subject withdrawn from the study?
text
C2349954 (UMLS CUI [1])
Code List
Was the subject withdrawn from the study?
CL Item
Yes* (Y)
CL Item
No (N)
Item
If Yes, tick the primary reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
Code List
If Yes, tick the primary reason for withdrawal:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropirate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Other (Z)
Primary Reason of Withdrawal Specification
Item
If Yes, tick the primary reason for withdrawal: If Other, specify:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item Group
Investigator's Signature
C2346576 (UMLS CUI-1)
Investigature's name
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below. Investigator's name (print)
text
C2346576 (UMLS CUI [1])
Date of Report
Item
Date of Report
date
C1302584 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial